Showing 6711-6720 of 19337 results for "".
A Successful and Safe Stem Cell Therapy for Progressive MS
https://reachmd.com/programs/neurofrontiers/a-successful-and-safe-stem-cell-therapy-for-progressive-ms/17928/Dive into the phase 1 study that was successful in showing stem cell therapy for people with active and nonactive progressive MS is doable.The Collateral Damage of “Non-Essential” Procedure Designations
https://reachmd.com/programs/covid-19-frontlines/collateral-damage-non-essential-procedure-designations/11377/Are the delays and cancellations of non-emergent surgeries and procedures creating new ramifications for patient health that may be felt for years?The 2 Overlooked Truths Reshaping the Future of Aesthetic Medicine
https://reachmd.com/ma-issues-index/jan-feb-2026-issue/the-2-overlooked-truths-reshaping-the-future-of-aesthetic-medicine/54439/Reviewing the Treatment Landscape for Duchenne Muscular Dystrophy
https://reachmd.com/programs/neurofrontiers/reviewing-the-treatment-landscape-for-duchenne-muscular-dystrophy/16066/Although there is currently no cure, what treatment options are available for our patients with Duchenne muscular dystrophy?Exploring the Role of Nutrition in Managing Neurological Disorders
https://reachmd.com/programs/neurofrontiers/exploring-the-role-of-nutrition-in-managing-neurological-disorders/24168/Find out how the Mediterranean, DASH, and MIND diets play a role in the management of neurological diseases.Optimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
https://reachmd.com/programs/clinicians-roundtable/optimizing-colorectal-cancer-screening-a-stress-test-of-current-guidelines/36408/Conflicting colorectal cancer screening (CRC) guidelines have sometimes led to confusion over optimal starting ages and strategies. Join Dr. Pedro Nascimento de Lima as he walks through a comprehensive modeling study that tested 26 different strategies over 4,000 scenarios to test how and when it isAEGEAN Trial: The Role of Perioperative Durvalumab in NSCLC
https://reachmd.com/programs/project-oncology/aegean-trial-the-role-of-perioperative-durvalumab-in-nsclc/16500/Explore the results of the AEGAN trial that focused on the use of neoadjuvant durvalumab in non-small cell lung cancer care.How the COVID-19 Pandemic Exposed Gaps in US Hospital Preparedness
https://reachmd.com/programs/clinicians-roundtable/how-the-covid-19-pandemic-exposed-gaps-in-us-hospital-preparedness/36413/Hospitals were especially vulnerable during the COVID-19 pandemic, with regulatory barriers, a lack of resources, and disjointed communication compounding the burden of the disease. Tune in to hear Dr. Amesh Adaljia examine the structural and systemic challenges to pandemic preparedness and discussEvolving Treatments: A Review of What’s in the Pipeline
https://reachmd.com/programs/lipid-luminations/evolving-treatments-a-review-of-whats-in-the-pipeline/6630/Host Dr. Alan Brown and guest, Dr. Harold Bays discuss the evolving treatments in lipid management and what we will be expecting in the future. They will address the role of niacin, the status of laropiprant, an overview of fish oils and omega-3 fatty acids and the novel approaches being used in todComing & Going: November/December 2022
https://reachmd.com/ma-issues-index/2022-nov-dec/coming-going-novemberdecember-2022/35236/